3.22.1 html 147 239 1 false 57 0 false 6 false false R1.htm 0001001 - Document - Cover Page Sheet http://www.antarespharma.com/role/CoverPage Cover Page Cover 1 false false R2.htm 1001002 - Statement - Condensed Consolidated Balance Sheets (Unaudited) Sheet http://www.antarespharma.com/role/CondensedConsolidatedBalanceSheetsUnaudited Condensed Consolidated Balance Sheets (Unaudited) Statements 2 false false R3.htm 1002003 - Statement - Condensed Consolidated Balance Sheets (Unaudited) (Parenthetical) Sheet http://www.antarespharma.com/role/CondensedConsolidatedBalanceSheetsUnauditedParenthetical Condensed Consolidated Balance Sheets (Unaudited) (Parenthetical) Statements 3 false false R4.htm 1003004 - Statement - Consolidated Statements of Operations (Unaudited) Sheet http://www.antarespharma.com/role/ConsolidatedStatementsofOperationsUnaudited Consolidated Statements of Operations (Unaudited) Statements 4 false false R5.htm 1004005 - Statement - Consolidated Statements of Comprehensive Income (Loss) (Unaudited) Sheet http://www.antarespharma.com/role/ConsolidatedStatementsofComprehensiveIncomeLossUnaudited Consolidated Statements of Comprehensive Income (Loss) (Unaudited) Statements 5 false false R6.htm 1005006 - Statement - Consolidated Statements of Stockholders' Equity (Unaudited) Sheet http://www.antarespharma.com/role/ConsolidatedStatementsofStockholdersEquityUnaudited Consolidated Statements of Stockholders' Equity (Unaudited) Statements 6 false false R7.htm 1006007 - Statement - Condensed Consolidated Statements of Cash Flows (Unaudited) Sheet http://www.antarespharma.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited Condensed Consolidated Statements of Cash Flows (Unaudited) Statements 7 false false R8.htm 2101101 - Disclosure - Description of Business Sheet http://www.antarespharma.com/role/DescriptionofBusiness Description of Business Notes 8 false false R9.htm 2102102 - Disclosure - Summary of Significant Accounting Policies Sheet http://www.antarespharma.com/role/SummaryofSignificantAccountingPolicies Summary of Significant Accounting Policies Notes 9 false false R10.htm 2107103 - Disclosure - Inventories Sheet http://www.antarespharma.com/role/Inventories Inventories Notes 10 false false R11.htm 2111104 - Disclosure - Property and Equipment Sheet http://www.antarespharma.com/role/PropertyandEquipment Property and Equipment Notes 11 false false R12.htm 2114105 - Disclosure - Long-Term Debt Sheet http://www.antarespharma.com/role/LongTermDebt Long-Term Debt Notes 12 false false R13.htm 2118106 - Disclosure - Share Based Compensation Sheet http://www.antarespharma.com/role/ShareBasedCompensation Share Based Compensation Notes 13 false false R14.htm 2124107 - Disclosure - Sale of Assets Sheet http://www.antarespharma.com/role/SaleofAssets Sale of Assets Notes 14 false false R15.htm 2126108 - Disclosure - Revenues, Significant Customers and Concentrations of Risk Sheet http://www.antarespharma.com/role/RevenuesSignificantCustomersandConcentrationsofRisk Revenues, Significant Customers and Concentrations of Risk Notes 15 false false R16.htm 2131109 - Disclosure - Income Taxes Sheet http://www.antarespharma.com/role/IncomeTaxes Income Taxes Notes 16 false false R17.htm 2133110 - Disclosure - Earnings (Loss) per Share Sheet http://www.antarespharma.com/role/EarningsLossperShare Earnings (Loss) per Share Notes 17 false false R18.htm 2136111 - Disclosure - Commitments and Contingencies Sheet http://www.antarespharma.com/role/CommitmentsandContingencies Commitments and Contingencies Notes 18 false false R19.htm 2138112 - Disclosure - Subsequent Events Sheet http://www.antarespharma.com/role/SubsequentEvents Subsequent Events Notes 19 false false R20.htm 2203201 - Disclosure - Summary of Significant Accounting Policies (Policies) Sheet http://www.antarespharma.com/role/SummaryofSignificantAccountingPoliciesPolicies Summary of Significant Accounting Policies (Policies) Policies http://www.antarespharma.com/role/SummaryofSignificantAccountingPolicies 20 false false R21.htm 2304301 - Disclosure - Summary of Significant Accounting Policies (Tables) Sheet http://www.antarespharma.com/role/SummaryofSignificantAccountingPoliciesTables Summary of Significant Accounting Policies (Tables) Tables http://www.antarespharma.com/role/SummaryofSignificantAccountingPolicies 21 false false R22.htm 2308302 - Disclosure - Inventories (Tables) Sheet http://www.antarespharma.com/role/InventoriesTables Inventories (Tables) Tables http://www.antarespharma.com/role/Inventories 22 false false R23.htm 2312303 - Disclosure - Property and Equipment (Tables) Sheet http://www.antarespharma.com/role/PropertyandEquipmentTables Property and Equipment (Tables) Tables http://www.antarespharma.com/role/PropertyandEquipment 23 false false R24.htm 2315304 - Disclosure - Long-Term Debt (Tables) Sheet http://www.antarespharma.com/role/LongTermDebtTables Long-Term Debt (Tables) Tables http://www.antarespharma.com/role/LongTermDebt 24 false false R25.htm 2319305 - Disclosure - Share Based Compensation (Tables) Sheet http://www.antarespharma.com/role/ShareBasedCompensationTables Share Based Compensation (Tables) Tables http://www.antarespharma.com/role/ShareBasedCompensation 25 false false R26.htm 2327306 - Disclosure - Revenues, Significant Customers and Concentrations of Risk (Tables) Sheet http://www.antarespharma.com/role/RevenuesSignificantCustomersandConcentrationsofRiskTables Revenues, Significant Customers and Concentrations of Risk (Tables) Tables http://www.antarespharma.com/role/RevenuesSignificantCustomersandConcentrationsofRisk 26 false false R27.htm 2334307 - Disclosure - Earnings (Loss) per Share (Tables) Sheet http://www.antarespharma.com/role/EarningsLossperShareTables Earnings (Loss) per Share (Tables) Tables http://www.antarespharma.com/role/EarningsLossperShare 27 false false R28.htm 2405401 - Disclosure - Summary of Significant Accounting Policies - Additional Information (Detail) Sheet http://www.antarespharma.com/role/SummaryofSignificantAccountingPoliciesAdditionalInformationDetail Summary of Significant Accounting Policies - Additional Information (Detail) Details 28 false false R29.htm 2406402 - Disclosure - Summary of Significant Accounting Policies - Summary of Estimated Useful Lives of Property and Equipment (Details) Sheet http://www.antarespharma.com/role/SummaryofSignificantAccountingPoliciesSummaryofEstimatedUsefulLivesofPropertyandEquipmentDetails Summary of Significant Accounting Policies - Summary of Estimated Useful Lives of Property and Equipment (Details) Details 29 false false R30.htm 2409403 - Disclosure - Inventories - Summary of Inventories (Detail) Sheet http://www.antarespharma.com/role/InventoriesSummaryofInventoriesDetail Inventories - Summary of Inventories (Detail) Details 30 false false R31.htm 2410404 - Disclosure - Inventories - Additional Information (Detail) Sheet http://www.antarespharma.com/role/InventoriesAdditionalInformationDetail Inventories - Additional Information (Detail) Details 31 false false R32.htm 2413405 - Disclosure - Property and Equipment - Summary of Property and Equipment (Detail) Sheet http://www.antarespharma.com/role/PropertyandEquipmentSummaryofPropertyandEquipmentDetail Property and Equipment - Summary of Property and Equipment (Detail) Details 32 false false R33.htm 2416406 - Disclosure - Long-Term Debt - Additional Information (Detail) Sheet http://www.antarespharma.com/role/LongTermDebtAdditionalInformationDetail Long-Term Debt - Additional Information (Detail) Details 33 false false R34.htm 2417407 - Disclosure - Long-Term Debt - Schedule of Future Principal Payments under Term Loan, Excluding End of Term Charge (Detail) Sheet http://www.antarespharma.com/role/LongTermDebtScheduleofFuturePrincipalPaymentsunderTermLoanExcludingEndofTermChargeDetail Long-Term Debt - Schedule of Future Principal Payments under Term Loan, Excluding End of Term Charge (Detail) Details 34 false false R35.htm 2420408 - Disclosure - Share Based Compensation - Additional Information (Detail) Sheet http://www.antarespharma.com/role/ShareBasedCompensationAdditionalInformationDetail Share Based Compensation - Additional Information (Detail) Details 35 false false R36.htm 2421409 - Disclosure - Share Based Compensation - Summary of Stock Option Activity (Detail) Sheet http://www.antarespharma.com/role/ShareBasedCompensationSummaryofStockOptionActivityDetail Share Based Compensation - Summary of Stock Option Activity (Detail) Details 36 false false R37.htm 2422410 - Disclosure - Share Based Compensation - Summary of PSU and RSU Award Activity Under Plan (Detail) Sheet http://www.antarespharma.com/role/ShareBasedCompensationSummaryofPSUandRSUAwardActivityUnderPlanDetail Share Based Compensation - Summary of PSU and RSU Award Activity Under Plan (Detail) Details 37 false false R38.htm 2423411 - Disclosure - Share Based Compensation - Summary of Share Based Compensation Allocation Expense (Detail) Sheet http://www.antarespharma.com/role/ShareBasedCompensationSummaryofShareBasedCompensationAllocationExpenseDetail Share Based Compensation - Summary of Share Based Compensation Allocation Expense (Detail) Details 38 false false R39.htm 2425412 - Disclosure - Sale of Assets - Additional Information (Details) Sheet http://www.antarespharma.com/role/SaleofAssetsAdditionalInformationDetails Sale of Assets - Additional Information (Details) Details 39 false false R40.htm 2428413 - Disclosure - Revenues, Significant Customers and Concentrations of Risk - Summary of Revenue Disaggregated by Types of Goods and Services and Major Product (Detail) Sheet http://www.antarespharma.com/role/RevenuesSignificantCustomersandConcentrationsofRiskSummaryofRevenueDisaggregatedbyTypesofGoodsandServicesandMajorProductDetail Revenues, Significant Customers and Concentrations of Risk - Summary of Revenue Disaggregated by Types of Goods and Services and Major Product (Detail) Details 40 false false R41.htm 2429414 - Disclosure - Revenues, Significant Customers and Concentrations of Risk - Summary of Revenues Disaggregated by Customer Location (Detail) Sheet http://www.antarespharma.com/role/RevenuesSignificantCustomersandConcentrationsofRiskSummaryofRevenuesDisaggregatedbyCustomerLocationDetail Revenues, Significant Customers and Concentrations of Risk - Summary of Revenues Disaggregated by Customer Location (Detail) Details 41 false false R42.htm 2430415 - Disclosure - Revenues, Significant Customers and Concentrations of Risk - Summary of Significant Customers from which the Company Derived 10% or More of Total Revenue (Detail) Sheet http://www.antarespharma.com/role/RevenuesSignificantCustomersandConcentrationsofRiskSummaryofSignificantCustomersfromwhichtheCompanyDerived10orMoreofTotalRevenueDetail Revenues, Significant Customers and Concentrations of Risk - Summary of Significant Customers from which the Company Derived 10% or More of Total Revenue (Detail) Details 42 false false R43.htm 2432416 - Disclosure - Income Taxes - Additional Information (Detail) Sheet http://www.antarespharma.com/role/IncomeTaxesAdditionalInformationDetail Income Taxes - Additional Information (Detail) Details 43 false false R44.htm 2435417 - Disclosure - Earnings (Loss) per Share - Summary of Computation for Basic and Diluted Net Earnings (Loss) per Share (Detail) Sheet http://www.antarespharma.com/role/EarningsLossperShareSummaryofComputationforBasicandDilutedNetEarningsLossperShareDetail Earnings (Loss) per Share - Summary of Computation for Basic and Diluted Net Earnings (Loss) per Share (Detail) Details http://www.antarespharma.com/role/EarningsLossperShareTables 44 false false R45.htm 2437418 - Disclosure - Commitments and Contingencies - Additional Information (Detail) Sheet http://www.antarespharma.com/role/CommitmentsandContingenciesAdditionalInformationDetail Commitments and Contingencies - Additional Information (Detail) Details 45 false false R46.htm 2439419 - Disclosure - Subsequent Events (Details) Sheet http://www.antarespharma.com/role/SubsequentEventsDetails Subsequent Events (Details) Details http://www.antarespharma.com/role/SubsequentEvents 46 false false All Reports Book All Reports atrs-20220331.htm atrs-20220331.xsd atrs-20220331_cal.xml atrs-20220331_def.xml atrs-20220331_lab.xml atrs-20220331_pre.xml atrs-20220331x10qexx311.htm atrs-20220331x10qexx312.htm atrs-20220331x10qexx321.htm atrs-20220331x10qexx322.htm atrs-20220331_g1.jpg http://fasb.org/us-gaap/2021-01-31 http://xbrl.sec.gov/dei/2021q4 true true